2016
DOI: 10.1177/0897190016680978
|View full text |Cite
|
Sign up to set email alerts
|

Successful Reversal of Bradycardia and Dyspnea With Aminophylline After Ticagrelor Load

Abstract: A 69-year-old male underwent elective percutaneous coronary intervention requiring placement of a drug-eluting stent to the first obtuse marginal artery. Four hours following the administration of a ticagrelor loading dose, he developed dyspnea and sinus pauses. Aminophylline was administered and resulted in immediate and sustained symptom resolution. Ticagrelor has been associated with dyspnea and bradyarrhythmias, both attributed to increased adenosine exposure. Ticagrelor inhibits reuptake of intracellular … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 21 publications
0
11
0
Order By: Relevance
“…Ticagrelor-induced bradycardia and its reversal has been reported in several case reports. [5][6][7][8] In the PLATO trial, ventricular pauses of more than 3 s and more than 5 s were noted in 5.8% and 2.0% of patients, respectively, in first week. After one month, 2.1% and 0.8% of patients developed ventricular pauses >3 s and >5 s, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…Ticagrelor-induced bradycardia and its reversal has been reported in several case reports. [5][6][7][8] In the PLATO trial, ventricular pauses of more than 3 s and more than 5 s were noted in 5.8% and 2.0% of patients, respectively, in first week. After one month, 2.1% and 0.8% of patients developed ventricular pauses >3 s and >5 s, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…Based on published case reports theophylline infusions may have positive effect on those symptoms, causing their remission. 41 Our experiences with the drug are similar, but there is a need for evidence from clinical trials. 42 As in none of the clinical trials using ticagrelor, patients were treated with theophylline or other methylxanthine drugs, currently there is no recommendation on this aspect neither by European Medicines Agency nor Food and Drug Administration.…”
Section: Managament Of Ticagrelor-related Dyspnoeamentioning
confidence: 99%
“…Noteworthy, in one case report both bradycardia and dyspnea were reversed using aminophylline, suggesting that administration of aminophylline might counteract the adenosine-related adverse effects of ticagrelor. 74 …”
Section: Mechanism Underlying the Pleiotropic Effects Of Ticagrelormentioning
confidence: 99%